These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24900507)
1. Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design. Villalta-Romero F; Gortat A; Herrera AE; Arguedas R; Quesada J; de Melo RL; Calvete JJ; Montero M; Murillo R; Rucavado A; Gutiérrez JM; Pérez-Payá E ACS Med Chem Lett; 2012 Jul; 3(7):540-3. PubMed ID: 24900507 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper. Escalante T; Franceschi A; Rucavado A; Gutiérrez JM Biochem Pharmacol; 2000 Jul; 60(2):269-74. PubMed ID: 10825472 [TBL] [Abstract][Full Text] [Related]
3. A neutralizing recombinant single chain antibody, scFv, against BaP1, A P-I hemorrhagic metalloproteinase from Bothrops asper snake venom. Castro JM; Oliveira TS; Silveira CR; Caporrino MC; Rodriguez D; Moura-da-Silva AM; Ramos OH; Rucavado A; Gutiérrez JM; Magalhães GS; Faquim-Mauro EL; Fernandes I Toxicon; 2014 Sep; 87():81-91. PubMed ID: 24887282 [TBL] [Abstract][Full Text] [Related]
4. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation. Rucavado A; Escalante T; Gutiérrez JM Toxicon; 2004 Mar; 43(4):417-24. PubMed ID: 15051405 [TBL] [Abstract][Full Text] [Related]
5. Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom. Rucavado A; Henríquez M; García J; Gutiérrez JM Toxicon; 2008 Dec; 52(7):754-9. PubMed ID: 18824013 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical and biological characterization of monoclonal antibodies against BaP1, a metalloproteinase from Bothrops asper snake venom. Fernandes I; Assumpção GG; Silveira CR; Faquim-Mauro EL; Tanjoni I; Carmona AK; Alves MF; Takehara HA; Rucavado A; Ramos OH; Moura-da-Silva AM; Gutiérrez JM Toxicon; 2010 Nov; 56(6):1059-65. PubMed ID: 20674587 [TBL] [Abstract][Full Text] [Related]
7. Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom. Arias AS; Rucavado A; Gutiérrez JM Toxicon; 2017 Jun; 132():40-49. PubMed ID: 28400263 [TBL] [Abstract][Full Text] [Related]
8. Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation. Mora J; Mora R; Lomonte B; Gutiérrez JM PLoS Negl Trop Dis; 2008; 2(10):e318. PubMed ID: 18923712 [TBL] [Abstract][Full Text] [Related]
9. Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Local Tissue Damage Induced by a Type P-I Snake Venom Metalloproteinase. Preciado LM; Pereañez JA; Comer J Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31861940 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Rucavado A; Escalante T; Franceschi A; Chaves F; León G; Cury Y; Ovadia M; Gutiérrez JM Am J Trop Med Hyg; 2000; 63(5-6):313-9. PubMed ID: 11421384 [TBL] [Abstract][Full Text] [Related]
11. Role of collagens and perlecan in microvascular stability: exploring the mechanism of capillary vessel damage by snake venom metalloproteinases. Escalante T; Ortiz N; Rucavado A; Sanchez EF; Richardson M; Fox JW; Gutiérrez JM PLoS One; 2011; 6(12):e28017. PubMed ID: 22174764 [TBL] [Abstract][Full Text] [Related]
12. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper. Rucavado A; Escalante T; Teixeira CF; Fernándes CM; Diaz C; Gutiérrez JM Mediators Inflamm; 2002 Apr; 11(2):121-8. PubMed ID: 12061424 [TBL] [Abstract][Full Text] [Related]
13. High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: insight into inhibitor binding. Lingott T; Schleberger C; Gutiérrez JM; Merfort I Biochemistry; 2009 Jul; 48(26):6166-74. PubMed ID: 19485419 [TBL] [Abstract][Full Text] [Related]
14. Discovery of small molecule inhibitors for the snake venom metalloprotease BaP1 using in silico and in vitro tests. Villalta-Romero F; Borro L; Mandic B; Escalante T; Rucavado A; Gutiérrez JM; Neshich G; Tasic L Bioorg Med Chem Lett; 2017 May; 27(9):2018-2022. PubMed ID: 28347665 [TBL] [Abstract][Full Text] [Related]
19. High resolution analysis of snake venom metalloproteinase (SVMP) peptide bond cleavage specificity using proteome based peptide libraries and mass spectrometry. Paes Leme AF; Escalante T; Pereira JG; Oliveira AK; Sanchez EF; Gutiérrez JM; Serrano SM; Fox JW J Proteomics; 2011 Apr; 74(4):401-10. PubMed ID: 21156218 [TBL] [Abstract][Full Text] [Related]
20. Site mutation of residues in a loop surrounding the active site of a PI snake venom metalloproteinase abrogates its hemorrhagic activity. Camacho E; Escalante T; Remans K; Gutiérrez JM; Rucavado A Biochem Biophys Res Commun; 2019 May; 512(4):859-863. PubMed ID: 30929924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]